Coronary calcification score: the coronary-risk impact factor

被引:60
作者
Thompson, GR [1 ]
Partridge, J
机构
[1] Hammersmith Hosp, Imperial Coll, Fac Med, Div Invest Sci, London W12 0NN, England
[2] Harefield Hosp, Harefield UB9 6JH, Middx, England
关键词
D O I
10.1016/S0140-6736(04)15544-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context Identification of asymptomatic high-risk individuals is integral to current policies for preventing coronary heart disease, but existing methods of estimating risk lack, sensitivity. To overcome this limitation increasing use is being made of non-invasive methods to detect subclinical coronary artery disease-eg, computed tomography (CT) to scan for coronary artery calcification. The location and extent of calcification correlate closely with pathological and angiographic abnormalities, but whether such calcification predicts clinical events, especially in younger individuals, is equivocal. Most data on coronary calcification have been obtained with electron-beam CT, but :recently multislice CT, which is more versatile, less expensive, and available in most large hospitals, has been increasingly used.
引用
收藏
页码:557 / 559
页数:3
相关论文
共 30 条
[1]   Influence of lipid-lowering therapy on the progression of coronary artery calcification - A prospective evaluation [J].
Achenbach, S ;
Ropers, D ;
Pohle, K ;
Leber, A ;
Thilo, C ;
Knez, A ;
Menendez, T ;
Maeffert, R ;
Kusus, M ;
Regenfus, M ;
Bickel, A ;
Haberl, R ;
Steinbeck, G ;
Moshage, W ;
Daniel, WG .
CIRCULATION, 2002, 106 (09) :1077-1082
[2]   AN UPDATED CORONARY RISK PROFILE - A STATEMENT FOR HEALTH-PROFESSIONALS [J].
ANDERSON, KM ;
WILSON, PWF ;
ODELL, PM ;
KANNEL, WB .
CIRCULATION, 1991, 83 (01) :356-362
[3]   Rationale and design of the St. Francis Heart Study: A randomized clinical trial of atorvastatin plus antioxidants in asymptomatic persons with elevated coronary calcification [J].
Arad, Y ;
Newstein, D ;
Roth, M ;
Guerci, AD .
CONTROLLED CLINICAL TRIALS, 2001, 22 (05) :553-572
[4]  
Brown BG, 2001, AM J CARDIOL, V88, p23E
[5]   Rates of progression of coronary calcium by electron beam tomography [J].
Budoff, MJ ;
Lane, KL ;
Bakhsheshi, H ;
Mao, S ;
Grassmann, BO ;
Friedman, BC ;
Brundage, BH .
AMERICAN JOURNAL OF CARDIOLOGY, 2000, 86 (01) :8-11
[6]   Effect of HMG-Coa reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography [J].
Callister, TQ ;
Raggi, P ;
Cooil, B ;
Lippolis, NJ ;
Russo, DJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (27) :1972-1978
[7]   European guidelines on cardiovascular disease prevention in clinical practice -: Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice [J].
De Backer, G ;
Ambrosioni, E ;
Borch-Johnsen, K ;
Brotons, C ;
Cifkova, R ;
Dallongeville, J ;
Ebrahim, S ;
Faergeman, O ;
Graham, I ;
Mancia, G ;
Cats, VM ;
Orth-Gomér, K ;
Perk, J ;
Pyörälä, K ;
Rodicio, JL ;
Sans, S ;
Sansoy, V ;
Sechtem, U ;
Silber, S ;
Thomsen, T ;
Wood, D .
EUROPEAN HEART JOURNAL, 2003, 24 (17) :1601-1610
[8]   Coronary heart disease deaths and infarctions in people with little or no coronary calcium [J].
Doherty, TM ;
Wong, ND ;
Shavelle, RM ;
Tang, WY ;
Detrano, RC .
LANCET, 1999, 353 (9146) :41-42
[9]   Coronary calcification and predicted risk of coronary heart disease in asymptomatic men with hypercholesterolaemia [J].
Elkeles, RS ;
Dunlop, A ;
Thompson, GR ;
Neuwirth, C ;
Gibson, K ;
Rubens, MB ;
Underwood, SR .
JOURNAL OF CARDIOVASCULAR RISK, 2002, 9 (06) :349-353
[10]   Selecting asymptomatic patients for coronary computed tomography or electrocardiographic exercise testing [J].
Greenland, P ;
Gaziano, JM .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (05) :465-473